Cargando…

Correction: Novel Gut-Based Pharmacology of Metformin in Patients with Type 2 Diabetes Mellitus

Detalles Bibliográficos
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2014
Materias:	Correction
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4143347/ http://dx.doi.org/10.1371/journal.pone.0106594

Ejemplares similares

Novel Gut-Based Pharmacology of Metformin in Patients with Type 2 Diabetes Mellitus
por: Napolitano, Antonella, et al.
Publicado: (2014)

Correction: Assessment of efficacy and tolerability of once-daily extended release metformin in patients with type 2 diabetes mellitus
por: Levy, Juliana, et al.
Publicado: (2010)

Correction to “Gut microbiota dysbiosis in Chinese children with type 1 diabetes mellitus: An observational study”
por: Liu, Xia, et al.
Publicado: (2022)

Correction: Comparison of SGLT2 inhibitors with DPP4 inhibitors combined with metformin in patients with acute myocardial infarction and diabetes mellitus
por: Lyu, Young Sang, et al.
Publicado: (2023)

Correction: Cognitive Impairment in Type 2 Diabetes Mellitus
por: Malik, Aimen, et al.
Publicado: (2022)

Effects of Metformin on the Gut Microbiota in Obesity and Type 2 Diabetes Mellitus
por: Zhang, Qi, et al.
Publicado: (2020)

Correction: Dapagliflozin add-on to metformin in type 2 diabetes inadequately controlled with metformin: a randomized, double-blind, placebo-controlled 102-week trial
por: Bailey, Clifford J, et al.
Publicado: (2013)

Correction: A novel therapeutic approach to colorectal cancer in diabetes: role of metformin and rapamycin
por: Geagea, Alice Gerges, et al.
Publicado: (2019)

Correction: Pattern of macronutrients intake among type-2 diabetes mellitus (T2DM) patients in Malaysia
por: Md Isa, Zaleha, et al.
Publicado: (2023)

Correction: Surgical ablation for atrial fibrillation: impact of Diabetes Mellitus type 2
por: Kogan, Alexander, et al.
Publicado: (2023)

Correction: Cardiovascular Effect of Incretin-Based Therapy in Patients with Type 2 Diabetes Mellitus: Systematic Review and Meta-Analysis
por: Kim, Je-Yon, et al.
Publicado: (2018)

Gut Hormone Pharmacology of a Novel GPR119 Agonist (GSK1292263), Metformin, and Sitagliptin in Type 2 Diabetes Mellitus: Results from Two Randomized Studies
por: Nunez, Derek J., et al.
Publicado: (2014)

Correction: Plasma 1-deoxysphingolipids are early predictors of incident type 2 diabetes mellitus
por: Mwinyi, J., et al.
Publicado: (2017)

Correction: Novel lipid indicators and the risk of type 2 diabetes mellitus among Chinese hypertensive patients: findings from the Guangzhou Heart Study
por: Deng, Hai, et al.
Publicado: (2023)

The Relationship between the Gut Microbiome and Metformin as a Key for Treating Type 2 Diabetes Mellitus
por: Lee, Chae Bin, et al.
Publicado: (2021)

Are There Differences in Gut Microbiome in Patients with Type 2 Diabetes Treated by Metformin or Metformin and Insulin?
por: Dzięgielewska-Gęsiak, Sylwia, et al.
Publicado: (2022)

Correction: Diabetic retinopathy among type 2 diabetes mellitus patients in Sabah primary health clinics–Addressing the underlying factors
por: Naserrudin, Nurul Athirah, et al.
Publicado: (2022)

Correction to: The prevalence and risk factors of peripheral neuropathy among patients with type 2 diabetes mellitus; the case of Jordan
por: Khawaja, Nahla, et al.
Publicado: (2018)

Correction to: Effect of liraglutide on cardiac function in patients with type 2 diabetes mellitus: randomized placebo-controlled trial
por: Bizino, Maurice B., et al.
Publicado: (2019)

Correction: Plasma microRNAs biomarkers in mild cognitive impairment among patients with type 2 diabetes mellitus
por: Salama, Iman I., et al.
Publicado: (2020)

Correction: Prevalence of limited health literacy among patients with type 2 diabetes mellitus: A systematic review
por: Abdullah, Adina, et al.
Publicado: (2022)

Correction to: Cost Analysis of FreeStyle Libre(®) 2 System in Type 2 Diabetes Mellitus Population
por: Oyagüez, Itziar, et al.
Publicado: (2021)

Correction to: “Cardiovascular Benefits of Empagliflozin Are Associated With Gut Microbiota and Plasma Metabolites in Type 2 Diabetes”
Publicado: (2022)

Correction to: Effects of probiotics on type II diabetes mellitus: a meta-analysis
por: Tao, Yun-Wen, et al.
Publicado: (2020)

Correction: Gut microbiome analysis of type 2 diabetic patients from the Chinese minority ethnic groups the Uygurs and Kazaks
por: Wang, Ye, et al.
Publicado: (2021)

Metformin and Risk of Hypertension in Taiwanese Patients With Type 2 Diabetes Mellitus
por: Tseng, Chin‐Hsiao
Publicado: (2018)

Metformin and lung cancer risk in patients with type 2 diabetes mellitus
por: Tseng, Chin-Hsiao
Publicado: (2017)

Metformin Use and Leukemia Risk in Patients With Type 2 Diabetes Mellitus
por: Tseng, Chin-Hsiao
Publicado: (2020)

Correction: Diabetes-specific eating disorder and possible associated psychopathologies in adolescents with type 1 diabetes mellitus
por: Tarçın, Gürkan, et al.
Publicado: (2023)

Correction: Creatinine‑to‑cystatin C ratio as a marker of sarcopenia for identifying osteoporosis in male patients with type 2 diabetes mellitus
por: Dai, Huifang, et al.
Publicado: (2022)

Correction: Survival Benefits of Metformin for Colorectal Cancer Patients with Diabetes: A Systematic Review and Meta-Analysis
Publicado: (2014)

The effects of metformin in type 1 diabetes mellitus
por: Beysel, Selvihan, et al.
Publicado: (2018)

Correction to: Metabolic Dyslipidemia and Cardiovascular Outcomes in Type 2 Diabetes Mellitus: Findings From the Look AHEAD Study
Publicado: (2021)

Correction to: Type 1 diabetes susceptibility alleles are associated with distinct alterations in the gut microbiota
por: Mullaney, Jane A., et al.
Publicado: (2018)

Correction: Rosiglitazone and Myocardial Infarction in Patients Previously Prescribed Metformin
por: Dormuth, Colin R., et al.
Publicado: (2010)

Correction to: One Year of Dapaglifozin Add-On Therapy Ameliorates Surrogate Indexes of Insulin Resistance and Adiposity in Patients with Type 2 Diabetes Mellitus
por: Radellini, Stefano, et al.
Publicado: (2021)

Correction: The potential effects and mechanisms of hispidulin in the treatment of diabetic retinopathy based on network pharmacology
por: Chen, Yao, et al.
Publicado: (2022)

Publisher Correction: Revealing links between gut microbiome and its fungal community in Type 2 Diabetes Mellitus among Emirati subjects: A pilot study
por: Al Bataineh, Mohammad Tahseen, et al.
Publicado: (2021)

Author Correction: Revealing links between gut microbiome and its fungal community in Type 2 Diabetes Mellitus among Emirati subjects: A pilot study
por: Al Bataineh, Mohammad Tahseen, et al.
Publicado: (2021)

Correction: Relationship of Dickkopf1 (DKK1) with Cardiovascular Disease and Bone Metabolism in Caucasian Type 2 Diabetes Mellitus
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_adf8pl45lvh1rhnl5i3aoc7qfk